Industry Research Reports
Home > Reports > Chemical & Material > Voriconazole API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Voriconazole API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Industry: Chemical & Material
Published Date: 2026-07-14
Pages: 136 Pages
Report ld: 6895918
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global market for Voriconazole API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Voriconazole is a antifungal, It was first introduced in the US for the treatment of infections in immune deficiency patients.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report provides a comprehensive view of the global market for Voriconazole API, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Voriconazole API market size, estimations, and forecasts are presented in terms of sales volume (Ton) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Voriconazole API.
MARKET SEGMENTATION
By Company
- Dr. Reddy's Laboratories
- Murli Krishna Pharma
- SGMR Pharmaceuticals
- Medichem
- Hunan Huateng Pharmaceutical
- Glenmark Pharmaceuticals
- ST Pharma
- Synergene
- Rundu Pharmaceutical
- Zhejiang Huahai Pharmaceutical
- Neuland Lab
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Oral Grade
- Injection Grade
Segment by Application
- Voriconazole Tablets
- Voriconazole Injection
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Voriconazole API manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Voriconazole API sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Voriconazole API sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Voriconazole API Product Introduction
1.2 Global Voriconazole API Market Size Forecast
1.2.1 Global Voriconazole API Sales Value (2021–2032)
1.2.2 Global Voriconazole API Sales Volume (2021–2032)
1.2.3 Global Voriconazole API Sales Price (2021–2032)
1.3 Voriconazole API Market Trends & Drivers
1.3.1 Voriconazole API Industry Trends
1.3.2 Voriconazole API Market Drivers & Opportunities
1.3.3 Voriconazole API Market Challenges
1.3.4 Voriconazole API Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Voriconazole API Players Revenue Ranking (2025)
2.2 Global Voriconazole API Revenue by Company (2021–2026)
2.3 Global Voriconazole API Sales Volume Ranking of Players (2025)
2.4 Global Voriconazole API Sales Volume by Company (2021–2026)
2.5 Global Voriconazole API Average Price by Company (2021–2026)
2.6 Key Manufacturers Voriconazole API Manufacturing Base and Headquarters
2.7 Key Manufacturers Voriconazole API Product Offerings
2.8 Key Manufacturers Start of Mass Production of Voriconazole API
2.9 Voriconazole API Market Competitive Analysis
2.9.1 Voriconazole API Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Voriconazole API Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Voriconazole API revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Voriconazole API Market Classification
3.1 Introduction by Type
3.1.1 Oral Grade
3.1.2 Injection Grade
3.1.3 Global Voriconazole API Sales Value by Type
3.1.3.1 Global Voriconazole API Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global Voriconazole API Sales Value, by Type (2021–2032)
3.1.3.3 Global Voriconazole API Sales Value, by Type (%), 2021–2032
3.1.4 Global Voriconazole API Sales Volume by Type
3.1.4.1 Global Voriconazole API Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Voriconazole API Sales Volume, by Type (2021–2032)
3.1.4.3 Global Voriconazole API Sales Volume, by Type (%), 2021–2032
3.1.5 Global Voriconazole API Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Voriconazole Tablets
4.1.2 Voriconazole Injection
4.2 Global Voriconazole API Sales Value by Application
4.2.1 Global Voriconazole API Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Voriconazole API Sales Value, by Application (2021–2032)
4.2.3 Global Voriconazole API Sales Value, by Application (%), 2021–2032
4.3 Global Voriconazole API Sales Volume by Application
4.3.1 Global Voriconazole API Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Voriconazole API Sales Volume, by Application (2021–2032)
4.3.3 Global Voriconazole API Sales Volume, by Application (%), 2021–2032
4.4 Global Voriconazole API Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Voriconazole API Sales Value by Region
5.1.1 Global Voriconazole API Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Voriconazole API Sales Value by Region (2021–2026)
5.1.3 Global Voriconazole API Sales Value by Region (2027–2032)
5.1.4 Global Voriconazole API Sales Value by Region (%), 2021–2032
5.2 Global Voriconazole API Sales Volume by Region
5.2.1 Global Voriconazole API Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Voriconazole API Sales Volume by Region (2021–2026)
5.2.3 Global Voriconazole API Sales Volume by Region (2027–2032)
5.2.4 Global Voriconazole API Sales Volume by Region (%), 2021–2032
5.3 Global Voriconazole API Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Voriconazole API Sales Value, 2021–2032
5.4.2 North America Voriconazole API Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Voriconazole API Sales Value, 2021–2032
5.5.2 Europe Voriconazole API Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Voriconazole API Sales Value, 2021–2032
5.6.2 Asia Pacific Voriconazole API Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Voriconazole API Sales Value, 2021–2032
5.7.2 South America Voriconazole API Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Voriconazole API Sales Value, 2021–2032
5.8.2 Middle East & Africa Voriconazole API Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Voriconazole API Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Voriconazole API Sales Value and Sales Volume
6.2.1 Key Countries/Regions Voriconazole API Sales Value, 2021–2032
6.2.2 Key Countries/Regions Voriconazole API Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Voriconazole API Sales Value, 2021–2032
6.3.2 United States Voriconazole API Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Voriconazole API Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Voriconazole API Sales Value, 2021–2032
6.4.2 Europe Voriconazole API Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Voriconazole API Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Voriconazole API Sales Value, 2021–2032
6.5.2 China Voriconazole API Sales Value by Type (%), 2025 vs 2032
6.5.3 China Voriconazole API Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Voriconazole API Sales Value, 2021–2032
6.6.2 Japan Voriconazole API Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Voriconazole API Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Voriconazole API Sales Value, 2021–2032
6.7.2 South Korea Voriconazole API Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Voriconazole API Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Voriconazole API Sales Value, 2021–2032
6.8.2 Southeast Asia Voriconazole API Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Voriconazole API Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Voriconazole API Sales Value, 2021–2032
6.9.2 India Voriconazole API Sales Value by Type (%), 2025 vs 2032
6.9.3 India Voriconazole API Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Dr. Reddy's Laboratories
7.1.1 Dr. Reddy's Laboratories Company Information
7.1.2 Dr. Reddy's Laboratories Introduction and Business Overview
7.1.3 Dr. Reddy's Laboratories Voriconazole API Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Dr. Reddy's Laboratories Voriconazole API Product Offerings
7.1.5 Dr. Reddy's Laboratories Recent Developments
7.2 Murli Krishna Pharma
7.2.1 Murli Krishna Pharma Company Information
7.2.2 Murli Krishna Pharma Introduction and Business Overview
7.2.3 Murli Krishna Pharma Voriconazole API Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Murli Krishna Pharma Voriconazole API Product Offerings
7.2.5 Murli Krishna Pharma Recent Developments
7.3 SGMR Pharmaceuticals
7.3.1 SGMR Pharmaceuticals Company Information
7.3.2 SGMR Pharmaceuticals Introduction and Business Overview
7.3.3 SGMR Pharmaceuticals Voriconazole API Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 SGMR Pharmaceuticals Voriconazole API Product Offerings
7.3.5 SGMR Pharmaceuticals Recent Developments
7.4 Medichem
7.4.1 Medichem Company Information
7.4.2 Medichem Introduction and Business Overview
7.4.3 Medichem Voriconazole API Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Medichem Voriconazole API Product Offerings
7.4.5 Medichem Recent Developments
7.5 Hunan Huateng Pharmaceutical
7.5.1 Hunan Huateng Pharmaceutical Company Information
7.5.2 Hunan Huateng Pharmaceutical Introduction and Business Overview
7.5.3 Hunan Huateng Pharmaceutical Voriconazole API Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Hunan Huateng Pharmaceutical Voriconazole API Product Offerings
7.5.5 Hunan Huateng Pharmaceutical Recent Developments
7.6 Glenmark Pharmaceuticals
7.6.1 Glenmark Pharmaceuticals Company Information
7.6.2 Glenmark Pharmaceuticals Introduction and Business Overview
7.6.3 Glenmark Pharmaceuticals Voriconazole API Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Glenmark Pharmaceuticals Voriconazole API Product Offerings
7.6.5 Glenmark Pharmaceuticals Recent Developments
7.7 ST Pharma
7.7.1 ST Pharma Company Information
7.7.2 ST Pharma Introduction and Business Overview
7.7.3 ST Pharma Voriconazole API Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 ST Pharma Voriconazole API Product Offerings
7.7.5 ST Pharma Recent Developments
7.8 Synergene
7.8.1 Synergene Company Information
7.8.2 Synergene Introduction and Business Overview
7.8.3 Synergene Voriconazole API Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Synergene Voriconazole API Product Offerings
7.8.5 Synergene Recent Developments
7.9 Rundu Pharmaceutical
7.9.1 Rundu Pharmaceutical Company Information
7.9.2 Rundu Pharmaceutical Introduction and Business Overview
7.9.3 Rundu Pharmaceutical Voriconazole API Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Rundu Pharmaceutical Voriconazole API Product Offerings
7.9.5 Rundu Pharmaceutical Recent Developments
7.10 Zhejiang Huahai Pharmaceutical
7.10.1 Zhejiang Huahai Pharmaceutical Company Information
7.10.2 Zhejiang Huahai Pharmaceutical Introduction and Business Overview
7.10.3 Zhejiang Huahai Pharmaceutical Voriconazole API Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Zhejiang Huahai Pharmaceutical Voriconazole API Product Offerings
7.10.5 Zhejiang Huahai Pharmaceutical Recent Developments
7.11 Neuland Lab
7.11.1 Neuland Lab Company Information
7.11.2 Neuland Lab Introduction and Business Overview
7.11.3 Neuland Lab Voriconazole API Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Neuland Lab Voriconazole API Product Offerings
7.11.5 Neuland Lab Recent Developments
8 Industry Chain Analysis
8.1 Voriconazole API Industrial Chain
8.2 Voriconazole API Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Voriconazole API Sales Model
8.5.2 Sales Channels
8.5.3 Voriconazole API Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Voriconazole API Market Trends
Table 2. Voriconazole API Market Drivers & Opportunities
Table 3. Voriconazole API Market Challenges
Table 4. Voriconazole API Market Restraints
Table 5. Global Voriconazole API Revenue by Company (US$ Million), 2021–2026
Table 6. Global Voriconazole API Revenue Market Share by Company (2021–2026)
Table 7. Global Voriconazole API Sales Volume by Company (Ton), 2021–2026
Table 8. Global Voriconazole API Sales Volume Market Share by Company (2021–2026)
Table 9. Global Market Voriconazole API Price by Company (US$/Ton), 2021–2026
Table 10. Key Manufacturers Voriconazole API Manufacturing Base and Headquarters
Table 11. Key Manufacturers Voriconazole API Product Type
Table 12. Key Manufacturers Start of Mass Production of Voriconazole API
Table 13. Global Voriconazole API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Voriconazole API revenue, 2025
Table 15. Mergers & Acquisitions and Expansion Plans
Table 16. Global Voriconazole API Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 17. Global Voriconazole API Sales Value by Type (US$ Million), 2021–2026
Table 18. Global Voriconazole API Sales Value by Type (US$ Million), 2027–2032
Table 19. Global Voriconazole API Sales Market Share in Value by Type (2021–2026)
Table 20. Global Voriconazole API Sales Market Share in Value by Type (2027–2032)
Table 21. Global Voriconazole API Sales Volume by Type: 2021 vs 2025 vs 2032 (Ton)
Table 22. Global Voriconazole API Sales Volume by Type (Ton), 2021–2026
Table 23. Global Voriconazole API Sales Volume by Type (Ton), 2027–2032
Table 24. Global Voriconazole API Sales Market Share in Volume by Type (2021–2026)
Table 25. Global Voriconazole API Sales Market Share in Volume by Type (2027–2032)
Table 26. Global Voriconazole API Price by Type (US$/Ton), 2021–2026
Table 27. Global Voriconazole API Price by Type (US$/Ton), 2027–2032
Table 28. Global Voriconazole API Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 29. Global Voriconazole API Sales Value by Application (US$ Million), 2021–2026
Table 30. Global Voriconazole API Sales Value by Application (US$ Million), 2027–2032
Table 31. Global Voriconazole API Sales Market Share in Value by Application (2021–2026)
Table 32. Global Voriconazole API Sales Market Share in Value by Application (2027–2032)
Table 33. Global Voriconazole API Sales Volume by Application: 2021 vs 2025 vs 2032 (Ton)
Table 34. Global Voriconazole API Sales Volume by Application (Ton), 2021–2026
Table 35. Global Voriconazole API Sales Volume by Application (Ton), 2027–2032
Table 36. Global Voriconazole API Sales Market Share in Volume by Application (2021–2026)
Table 37. Global Voriconazole API Sales Market Share in Volume by Application (2027–2032)
Table 38. Global Voriconazole API Price by Application (US$/Ton), 2021–2026
Table 39. Global Voriconazole API Price by Application (US$/Ton), 2027–2032
Table 40. Global Voriconazole API Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 41. Global Voriconazole API Sales Value by Region (US$ Million), 2021–2026
Table 42. Global Voriconazole API Sales Value by Region (US$ Million), 2027–2032
Table 43. Global Voriconazole API Sales Value by Region (%), 2021–2026
Table 44. Global Voriconazole API Sales Value by Region (%), 2027–2032
Table 45. Global Voriconazole API Sales Volume by Region (Ton): 2021 vs 2025 vs 2032
Table 46. Global Voriconazole API Sales Volume by Region (Ton), 2021–2026
Table 47. Global Voriconazole API Sales Volume by Region (Ton), 2027–2032
Table 48. Global Voriconazole API Sales Volume by Region (%), 2021–2026
Table 49. Global Voriconazole API Sales Volume by Region (%), 2027–2032
Table 50. Global Voriconazole API Average Price by Region (US$/Ton), 2021–2026
Table 51. Global Voriconazole API Average Price by Region (US$/Ton), 2027–2032
Table 52. Key Countries/Regions Voriconazole API Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 53. Key Countries/Regions Voriconazole API Sales Value, (US$ Million), 2021–2026
Table 54. Key Countries/Regions Voriconazole API Sales Value, (US$ Million), 2027–2032
Table 55. Key Countries/Regions Voriconazole API Sales Volume, (Ton), 2021–2026
Table 56. Key Countries/Regions Voriconazole API Sales Volume, (Ton), 2027–2032
Table 57. Dr. Reddy's Laboratories Company Information
Table 58. Dr. Reddy's Laboratories Introduction and Business Overview
Table 59. Dr. Reddy's Laboratories Voriconazole API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 60. Dr. Reddy's Laboratories Voriconazole API Product Offerings
Table 61. Dr. Reddy's Laboratories Recent Developments
Table 62. Murli Krishna Pharma Company Information
Table 63. Murli Krishna Pharma Introduction and Business Overview
Table 64. Murli Krishna Pharma Voriconazole API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 65. Murli Krishna Pharma Voriconazole API Product Offerings
Table 66. Murli Krishna Pharma Recent Developments
Table 67. SGMR Pharmaceuticals Company Information
Table 68. SGMR Pharmaceuticals Introduction and Business Overview
Table 69. SGMR Pharmaceuticals Voriconazole API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 70. SGMR Pharmaceuticals Voriconazole API Product Offerings
Table 71. SGMR Pharmaceuticals Recent Developments
Table 72. Medichem Company Information
Table 73. Medichem Introduction and Business Overview
Table 74. Medichem Voriconazole API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 75. Medichem Voriconazole API Product Offerings
Table 76. Medichem Recent Developments
Table 77. Hunan Huateng Pharmaceutical Company Information
Table 78. Hunan Huateng Pharmaceutical Introduction and Business Overview
Table 79. Hunan Huateng Pharmaceutical Voriconazole API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 80. Hunan Huateng Pharmaceutical Voriconazole API Product Offerings
Table 81. Hunan Huateng Pharmaceutical Recent Developments
Table 82. Glenmark Pharmaceuticals Company Information
Table 83. Glenmark Pharmaceuticals Introduction and Business Overview
Table 84. Glenmark Pharmaceuticals Voriconazole API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 85. Glenmark Pharmaceuticals Voriconazole API Product Offerings
Table 86. Glenmark Pharmaceuticals Recent Developments
Table 87. ST Pharma Company Information
Table 88. ST Pharma Introduction and Business Overview
Table 89. ST Pharma Voriconazole API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 90. ST Pharma Voriconazole API Product Offerings
Table 91. ST Pharma Recent Developments
Table 92. Synergene Company Information
Table 93. Synergene Introduction and Business Overview
Table 94. Synergene Voriconazole API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 95. Synergene Voriconazole API Product Offerings
Table 96. Synergene Recent Developments
Table 97. Rundu Pharmaceutical Company Information
Table 98. Rundu Pharmaceutical Introduction and Business Overview
Table 99. Rundu Pharmaceutical Voriconazole API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 100. Rundu Pharmaceutical Voriconazole API Product Offerings
Table 101. Rundu Pharmaceutical Recent Developments
Table 102. Zhejiang Huahai Pharmaceutical Company Information
Table 103. Zhejiang Huahai Pharmaceutical Introduction and Business Overview
Table 104. Zhejiang Huahai Pharmaceutical Voriconazole API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 105. Zhejiang Huahai Pharmaceutical Voriconazole API Product Offerings
Table 106. Zhejiang Huahai Pharmaceutical Recent Developments
Table 107. Neuland Lab Company Information
Table 108. Neuland Lab Introduction and Business Overview
Table 109. Neuland Lab Voriconazole API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
Table 110. Neuland Lab Voriconazole API Product Offerings
Table 111. Neuland Lab Recent Developments
Table 112. Key Raw Materials Lists
Table 113. Key Suppliers of Raw Materials Lists
Table 114. Voriconazole API Downstream Customers
Table 115. Voriconazole API Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Voriconazole API Product Picture
Figure 2. Global Voriconazole API Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Voriconazole API Sales Value (US$ Million), 2021–2032
Figure 4. Global Voriconazole API Sales Volume (Ton), 2021–2032
Figure 5. Global Voriconazole API Sales Price (US$/Ton), 2021–2032
Figure 6. Voriconazole API Report Years Considered
Figure 7. Global Voriconazole API Players Revenue Ranking (US$ Million), 2025
Figure 8. Global Voriconazole API Sales Volume Ranking of Players (Ton), 2025
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Voriconazole API Revenue in 2025
Figure 10. Voriconazole API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 11. Oral Grade Picture
Figure 12. Injection Grade Picture
Figure 13. Global Voriconazole API Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Voriconazole API Sales Value Market Share by Type, 2025 & 2032
Figure 15. Global Voriconazole API Sales Volume by Type (Ton), 2021 vs 2025 vs 2032
Figure 16. Global Voriconazole API Sales Volume Market Share by Type, 2025 & 2032
Figure 17. Global Voriconazole API Price by Type (US$/Ton), 2021–2032
Figure 18. Product Picture of Voriconazole Tablets
Figure 19. Product Picture of Voriconazole Injection
Figure 20. Global Voriconazole API Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 21. Global Voriconazole API Sales Value Market Share by Application, 2025 & 2032
Figure 22. Global Voriconazole API Sales Volume by Application (Ton), 2021 vs 2025 vs 2032
Figure 23. Global Voriconazole API Sales Volume Market Share by Application, 2025 & 2032
Figure 24. Global Voriconazole API Price by Application (US$/Ton), 2021–2032
Figure 25. North America Voriconazole API Sales Value (US$ Million), 2021–2032
Figure 26. North America Voriconazole API Sales Value by Country (%), 2025 vs 2032
Figure 27. Europe Voriconazole API Sales Value (US$ Million), 2021–2032
Figure 28. Europe Voriconazole API Sales Value by Country (%), 2025 vs 2032
Figure 29. Asia Pacific Voriconazole API Sales Value (US$ Million), 2021–2032
Figure 30. Asia Pacific Voriconazole API Sales Value by Region (%), 2025 vs 2032
Figure 31. South America Voriconazole API Sales Value (US$ Million), 2021–2032
Figure 32. South America Voriconazole API Sales Value by Country (%), 2025 vs 2032
Figure 33. Middle East & Africa Voriconazole API Sales Value (US$ Million), 2021–2032
Figure 34. Middle East & Africa Voriconazole API Sales Value by Country (%), 2025 vs 2032
Figure 35. Key Countries/Regions Voriconazole API Sales Value (%), 2021–2032
Figure 36. Key Countries/Regions Voriconazole API Sales Volume (%), 2021–2032
Figure 37. United States Voriconazole API Sales Value (US$ Million), 2021–2032
Figure 38. United States Voriconazole API Sales Value by Type (%), 2025 vs 2032
Figure 39. United States Voriconazole API Sales Value by Application (%), 2025 vs 2032
Figure 40. Europe Voriconazole API Sales Value (US$ Million), 2021–2032
Figure 41. Europe Voriconazole API Sales Value by Type (%), 2025 vs 2032
Figure 42. Europe Voriconazole API Sales Value by Application (%), 2025 vs 2032
Figure 43. China Voriconazole API Sales Value (US$ Million), 2021–2032
Figure 44. China Voriconazole API Sales Value by Type (%), 2025 vs 2032
Figure 45. China Voriconazole API Sales Value by Application (%), 2025 vs 2032
Figure 46. Japan Voriconazole API Sales Value (US$ Million), 2021–2032
Figure 47. Japan Voriconazole API Sales Value by Type (%), 2025 vs 2032
Figure 48. Japan Voriconazole API Sales Value by Application (%), 2025 vs 2032
Figure 49. South Korea Voriconazole API Sales Value (US$ Million), 2021–2032
Figure 50. South Korea Voriconazole API Sales Value by Type (%), 2025 vs 2032
Figure 51. South Korea Voriconazole API Sales Value by Application (%), 2025 vs 2032
Figure 52. Southeast Asia Voriconazole API Sales Value (US$ Million), 2021–2032
Figure 53. Southeast Asia Voriconazole API Sales Value by Type (%), 2025 vs 2032
Figure 54. Southeast Asia Voriconazole API Sales Value by Application (%), 2025 vs 2032
Figure 55. India Voriconazole API Sales Value (US$ Million), 2021–2032
Figure 56. India Voriconazole API Sales Value by Type (%), 2025 vs 2032
Figure 57. India Voriconazole API Sales Value by Application (%), 2025 vs 2032
Figure 58. Voriconazole API Industrial Chain
Figure 59. Voriconazole API Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Voriconazole API market?
The top companies in the global Voriconazole API market are Dr. Reddy's Laboratories、Murli Krishna Pharma、SGMR Pharmaceuticals.
Related Reports
Global Voriconazole API Market Research Report 2026
The global Voriconazole API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 141
USD 2900.00
(Single User License)
Global Voriconazole API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Voriconazole API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-21
Pages: 160
USD 4900.00
(Single User License)
Global Voriconazole API Market Research Report 2025
The global market for Voriconazole API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 104
USD 2900.00
(Single User License)
Global Voriconazole API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Voriconazole API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 98
USD 4250.00
(Single User License)
Voriconazole API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Voriconazole API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 128
USD 3950.00
(Single User License)
Global Voriconazole API Market Insights, Forecast to 2030
Voriconazole is a antifungal, It was first introduced in the US for the treatment of infections in immune deficiency patients.
Published Date: 2024-04-12
Pages: 111
USD 4900.00
(Single User License)
Global Voriconazole API Market Research Report 2024
Voriconazole is a antifungal, It was first introduced in the US for the treatment of infections in immune deficiency patients.
Published Date: 2024-01-17
Pages: 95
USD 2900.00
(Single User License)
Voriconazole API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Voriconazole is a antifungal, It was first introduced in the US for the treatment of infections in immune deficiency patients.
Published Date: 2024-01-09
Pages: 130
USD 3950.00
(Single User License)
Global Voriconazole API Market Research Report 2026
The global Voriconazole API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 141
USD 2900.00 (Single User License)Global Voriconazole API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Voriconazole API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-21
Pages: 160
USD 4900.00 (Single User License)Global Voriconazole API Market Research Report 2025
The global market for Voriconazole API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 104
USD 2900.00 (Single User License)Global Voriconazole API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Voriconazole API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 98
USD 4250.00 (Single User License)Voriconazole API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Voriconazole API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 128
USD 3950.00 (Single User License)Global Voriconazole API Market Insights, Forecast to 2030
Voriconazole is a antifungal, It was first introduced in the US for the treatment of infections in immune deficiency patients.
Published: 2024-04-12
Pages: 111
USD 4900.00 (Single User License)Global Voriconazole API Market Research Report 2024
Voriconazole is a antifungal, It was first introduced in the US for the treatment of infections in immune deficiency patients.
Published: 2024-01-17
Pages: 95
USD 2900.00 (Single User License)Voriconazole API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Voriconazole is a antifungal, It was first introduced in the US for the treatment of infections in immune deficiency patients.
Published: 2024-01-09
Pages: 130
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now